Results 221 to 230 of about 382,255 (259)
Some of the next articles are maybe not open access.
Headache Currents, 2004
The NMDA Receptor Antagonist MK‐801 Reduces Fos‐like Immunoreactivity Within the Trigeminocervical Complex Following Superior Sagittal Sinus Stimulation in the Cat Expression of Fos protein is an indicator of neuronal perturbation and is readily observed in the caudal medulla and the spinal cord following trigeminovascular nociceptive
Jonas Broman +4 more
openaire +2 more sources
The NMDA Receptor Antagonist MK‐801 Reduces Fos‐like Immunoreactivity Within the Trigeminocervical Complex Following Superior Sagittal Sinus Stimulation in the Cat Expression of Fos protein is an indicator of neuronal perturbation and is readily observed in the caudal medulla and the spinal cord following trigeminovascular nociceptive
Jonas Broman +4 more
openaire +2 more sources
Glutamate Receptors and Glutamate Corticofugal Pathways
1986Although the neurochemical anatomy of many pathways in human brain has been studied, little attention has been paid to the human pyramidal system. This pathway is very important for voluntary motor control in vertebrates, and pyramidal tract pathology leads to hemiparesis or hemiplegia in primates and man (Phillips and Porter, 1977).
A. B. Young +3 more
openaire +1 more source
Pharmacology of the glutamate receptor
Progress in Neurobiology, 1988The history of pharmacological examinations of glutamate receptor agonists such as kainic acid, quisqualic acid, acromelic acid, L-CCG-I, DCG-IV and L-F2CCG-I was described. Kainic acid is one of the most potent excitants in the mammalian central neurons, and its powerful excitatory actions gave rise to the excitotoxic concept that glutamate destroys ...
openaire +3 more sources
Non-canonical Glutamate-Cysteine Ligase Activity Protects against Ferroptosis
Cell Metabolism, 2021Yun Pyo Kang +2 more
exaly
Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration
Neuropharmacology, 2021Jens V Andersen +2 more
exaly